Health Trials

Burkitt Leukemia

2

Review clinical trials related to Burkitt Leukemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

This phase II trial studies how well naive T-cell depletion works in preventing chronic graft-versus-host disease in children and young adults with blood cancers undergoing donor stem cell transplant. Sometimes the transplanted white blood cells from a donor attack the body's normal tissues (called graft versus host disease). Removing a particular type of T cell (naive T cells) from the donor cells before the transplant may stop this from happening.

Participants needed: 68
Trial details
Phase: Phase 2Age: 6-26Biological sex: AllType: InterventionalSponsor: Fred Hutchinson Cancer CenterUpdated: May 14, 2026Locations: 10
Eligibility criteria

Acute lymphoblastic leukemia (ALL) with < 5% marrow blasts. [+30]

Active central nervous system (CNS) disease. A patient may have a history of CNS... [+11]

Read more
Status: Recruiting

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

This is a single arm pilot study for patients with hematologic malignancies receiving unrelated or haploidentical related mobilized peripheral stem cells (PSCs) using the CliniMACS system for alpha/beta T cell depletion plus CD19+ B cell depletion with individualized ALC-based dosing of ATG to study impact on engraftment, GVHD, and disease free survival

Participants needed: 40
Trial details
Age: 0-25Biological sex: AllType: InterventionalSponsor: Medical College of WisconsinUpdated: May 13, 2026Locations: 1
Eligibility criteria

Patient age < 25 years. Both genders and all races eligible. [+21]

Patients who do not meet disease, organ, or infectious criteria. [+5]

Read more